Zobrazeno 1 - 10
of 132
pro vyhledávání: '"Yang-Te Tsai"'
Autor:
Shou-Hwa Han, Ching-yu Wang, Yang-Te Tsai, Shou-Dong Lee, Shu-chen Chien, Jaw Ching Wu, Chungming Chang, Cheng-po Hu, Ming-huey H. Chu
Publikováno v:
Liver. 8:198-207
The status of cellular cytotoxic activity in Hepatocellular Carcinoma (HCC) patients was compared to that in normal individuals by testing the cytotoxicity against K562 and five established HCC cell line targets. Natural killer (NK) activity of fresh
Autor:
Fa‐Yauh Lee, Chi‐Woon Kong, Kwang‐Juei Lo, Yang-Te Tsai, Shou-Dong Lee, Benjamin N. Chiang, Kuang‐Y Chen, Chii‐Shyan Lay
Publikováno v:
Liver. 7:223-227
— The acute effects of Nifedipine on hepatic venous pressure gradient (HVPG) and estimated hepatic blood flow (EHBF) were investigated in six patients with HBsAg-positive cirrhosis and portal hypertension by simultaneous hepatic venous catheterizat
Autor:
Cheng Yuan Peng, Chih Bin Chen, Cheng Ju Yu, Fa-Yauh Lee, Chii Shyan Lay, Yang-Te Tsai, Yi Liang Lai
Publikováno v:
Journal of Gastroenterology and Hepatology. 21:413-419
Background and Aim: To compare the efficacy and safety of endoscopic variceal ligation (EVL) with propranolol in prophylaxis on the rate of first esophageal variceal bleeding in patients with cirrhosis. Methods: A prospective, randomized trial was co
Autor:
Fa-Yauh Lee, Full-Young Chang, Wui‐Chiang Lee, Shou-Dong Lee, Ming-Chih Hou, Yang-Te Tsai, Han Chieh Lin
Publikováno v:
Journal of Gastroenterology and Hepatology. 14:370-375
Background: It has been suggested that increased blood haemoglobin attenuates splanchnic vasodilatation in portal-hypertensive rats by nitric oxide inactivation. However, the haemodynamic effect of anaemia in cirrhotic patients of varying severity ha
Autor:
Fa-Yauh Lee, Yee Chao, Rei-Hwa Lu, Shou-Dong Lee, Shwu-Ling Wu, Che-Chang Chan, Yang-Te Tsai, Sun-Sang Wang, Han Chieh Lin
Publikováno v:
Clinical Science. 98:419-425
To delineate the clinical roles of plasma cytokine or endotoxin levels in the natural course of infection in patients with decompensated cirrhosis, 66 cirrhotic patients were studied within a 1.5-year period. Plasma levels of tumour necrosis factor-
Autor:
Han Chieh Lin, Shou-Dong Lee, Huei-Min Cheng, Yang-Te Tsai, Chung-Pin Li, Fa-Yauh Lee, Shinn Jang Hwang, Haw-Jang Liu, Teh‐Fang Wang, Sun-Sang Wang
Publikováno v:
Journal of Gastroenterology and Hepatology. 12:445-449
Gall-bladder wall thickening is commonly seen in patients with cirrhosis, but its exact causes have not been well established. We evaluated clinical, biochemical and haemodynamic data of patients with cirrhosis with respect to the presence of thicken
Autor:
Sun-Sang Wang, Chau-Heng Chien, Shou-Dong Lee, Chii-Min Hwu, Yang-Te Tsai, Fa-Yauh Lee, Yee Chao, Shwu-Ling Wu, Paulus S. Wang, Chun-Chia Chen
Publikováno v:
Journal of Hepatology. 26:1128-1134
To realize the roles of peripheral vasodilatation and atrial natriuretic peptide in the formation of cirrhotic ascites, the effects of long-term administration of octreotide on carbon tetrachloride-induced cirrhotic rats were evaluated.Urine sodium e
Autor:
Shinn Jang Hwang, Ming-Chih Hou, Fa-Yauh Lee, Han-Chieh Lin, Shou-Dong Lee, Yi-Tsau Huang, May C-M. Yang, Li-Fen Lin, Shu-Min Li, Yang-Te Tsai, Sun-Sang Wang
Publikováno v:
Journal of Gastroenterology and Hepatology. 11:422-428
Plasma glucagon concentrations were measured in 160 cirrhotic patients (Pugh's grade A in 52 patients, Pugh's grade B in 64 patients and Pugh's grade C in 44 patients). These values were compared with plasma glucagon concentrations in 57 age and sex-
Publikováno v:
Journal of Gastroenterology and Hepatology. 11:391-395
In order to investigate the effects of verapamil on renal haemodynamics in rats with portal hypertension, verapamil was given at either a low (0.2 mg/kg) or high (2 mg/kg) dose to rats after portal vein ligation. An approximate 12% decrease in mean a
Autor:
Han-Chieh Lin, Yi-Tsau Huang, Pi-Chin Yu, Ming-Chih Hou, May C-M. Yang, Shu-Min Li, Yang-Te Tsai, Shou-Dong Lee
Publikováno v:
Hepatology. 23:537-543
The hemodynamic effects of long-term administration of octreotide in portal hypertension has not been established. In addition, whether long-term octreotide treatment prevents the development of portosystemic shunts has not yet been evaluated. Hence,